Australia markets closed

CBD Life Sciences Inc. (CBDL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 35.85k
Enterprise value 51.93k
Trailing P/E 0.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.58
Price/book (mrq)N/A
Enterprise value/revenue 0.42
Enterprise value/EBITDA -0.62

Trading information

Stock price history

Beta (5Y monthly) 56.59
52-week change 30.00%
S&P500 52-week change 320.07%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 37.07M
Avg vol (10-day) 37.26M
Shares outstanding 53.58k
Implied shares outstanding 6358.5M
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Feb 2019
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 305 Feb 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-411.87%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)138.19k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)242.80%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-3.22M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)303.09k
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-3.4M
Levered free cash flow (ttm)N/A